Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 24;10(11):2264.
doi: 10.3390/jcm10112264.

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

Affiliations

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

Mazen Osman et al. J Clin Med. .

Abstract

The accurate diagnosis of chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) subtypes with monocytic differentiation relies on the proper identification and quantitation of blast cells and blast-equivalent cells, including promonocytes. This distinction can be quite challenging given the cytomorphologic and immunophenotypic similarities among the monocytic cell precursors. The aim of this study was to assess the performance of convolutional neural networks (CNN) in separating monocytes from their precursors (i.e., promonocytes and monoblasts). We collected digital images of 935 monocytic cells that were blindly reviewed by five experienced morphologists and assigned into three subtypes: monocyte, promonocyte, and blast. The consensus between reviewers was considered as a ground truth reference label for each cell. In order to assess the performance of CNN models, we divided our data into training (70%), validation (10%), and test (20%) datasets, as well as applied fivefold cross validation. The CNN models did not perform well for predicting three monocytic subtypes, but their performance was significantly improved for two subtypes (monocyte vs. promonocytes + blasts). Our findings (1) support the concept that morphologic distinction between monocytic cells of various differentiation level is difficult; (2) suggest that combining blasts and promonocytes into a single category is desirable for improved accuracy; and (3) show that CNN models can reach accuracy comparable to human reviewers (0.78 ± 0.10 vs. 0.86 ± 0.05). As far as we know, this is the first study to separate monocytes from their precursors using CNN.

Keywords: artificial intelligence; chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) for acute monoblastic leukemia and acute monocytic leukemia; concordance between hematopathologists; digital imaging; improving diagnosis accuracy; monocytes; promonocytes and monoblasts.

PubMed Disclaimer

Conflict of interest statement

Mohamed Salama serves on the Board of Directors and has stock option at Techcyte Inc.

Figures

Figure 1
Figure 1
Examples of monocytes, promonocytes, and monoblasts with criteria.
Figure 2
Figure 2
t-SNE plots for the performance of the Inception_resnet model using configurations 1 and 2 on the test. In the configuration 1 plot, all promonocytes demonstrated similar features to blasts and some of monocytes were also not discernable from blasts. In the configuration 2 plot, promonocytes were distributed across monocyte and blast classes.

Similar articles

Cited by

References

    1. Arber D.A., Orazi A., Hasserjian R., Thiele J., Borowitz M.J., Le Beau M.M., Bloomfield C.D., Cazzola M., Vardiman J.W. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405. doi: 10.1182/blood-2016-03-643544. - DOI - PubMed
    1. Campo E., Harris N.L., Pileri S.A., Jaffe E.S., Stein H., Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Who Classification of Tum; Lyon, France: 2017.
    1. Arber D.A. Acute myeloid leukaemia, not otherwise specified. In: Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J., editors. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. IARC Press; Lyon, France: 2017. pp. 156–166.
    1. Arber D.A., Orazi A. Update on the pathologic diagnosis of chronic myelomonocytic leukemia. Mod. Pathol. 2019;32:732–740. doi: 10.1038/s41379-019-0215-y. - DOI - PubMed
    1. Bain B., Bain B.J., Matutes E. Chronic Myeloid Leukaemias. Clinical Publishing, Atlas Medical Pub Ltd.; New York, NY, USA: 2012.

Grants and funding